Fowl Cholera in Poultry: Etiology, Epidemiology, and Control

Introduction

Fowl cholera, also termed avian cholera or avian pasteurellosis, is a highly contagious and economically devastating septicemic bacterial disease affecting a wide range of avian species, including chickens, turkeys, ducks, geese, and game birds [1, 2, 3]. The disease is caused by the gram-negative coccobacillus Pasteurella multocida, a member of the family Pasteurellaceae [4, 5]. Fowl cholera represents a significant threat to global poultry production, causing substantial mortality, morbidity, and economic losses due to reduced egg production, increased treatment costs, and trade restrictions [6, 7]. This article provides an exhaustive review of the etiology, epidemiology, clinical presentation, pathology, diagnostic approaches, and control measures for fowl cholera in poultry, with a focus on the underlying biological and biophysical mechanisms.

Etiology: Pasteurella multocida

Taxonomic Classification and Biophysical Characteristics

Pasteurella multocida is a small, non-motile, gram-negative, facultatively anaerobic bacterium that typically appears as a coccobacillus or short rod (0.3 to 1.0 micrometers in diameter and 1.0 to 2.0 micrometers in length) [8, 9]. The organism is encapsulated, with the capsule being a critical virulence determinant that facilitates resistance to phagocytosis and complement-mediated killing [10, 11]. The cell wall contains lipopolysaccharide (LPS) with a conserved lipid A structure, but the outer core oligosaccharide exhibits significant phase variation, which is a key mechanism for immune evasion and host adaptation [12, 13]. The bacterium is catalase and oxidase positive, and it ferments a range of carbohydrates without gas production [14, 15].

Serotyping and Genotyping

P. multocida is classified into five capsular serogroups (A, B, D, E, and F) based on the antigenic structure of the capsule, and into 16 LPS serotypes based on the heat-stable somatic antigens [16, 17]. The capsular serogroups are determined by the presence of specific polysaccharide biosynthetic genes: capA (hyaluronic acid) for serogroup A, capB (uncharacterized) for serogroup B, capD (heparin-like) for serogroup D, capE (uncharacterized) for serogroup E, and capF (uncharacterized) for serogroup F [18, 19]. In poultry, the most common capsular serogroups associated with fowl cholera are A and D, with serogroup A being the predominant cause of acute outbreaks [20, 21]. LPS genotyping, using PCR targeting the hyaD/hyaC and lps loci, further refines the classification, with LPS type L3 being the most frequently identified in layer flocks [22, 23].

Virulence Factors

P. multocida possesses a diverse array of virulence factors that enable colonization, invasion, and evasion of host immune defenses. Key virulence determinants include:

• Capsule (CapA): The hyaluronic acid capsule of serogroup A inhibits phagocytosis and complement activation, and is essential for full virulence [24, 25].
• Adhesins and Fimbriae: Fimbrial proteins (e.g., Fim4, FimA, PfhA) and the filamentous hemagglutinin (FhaB) mediate attachment to host respiratory epithelial cells [26, 27].
• Outer Membrane Proteins (OMPs): Proteins such as Oma87 and PlpB function as porins and iron acquisition receptors, and are critical for survival in the iron-restricted host environment [28, 29].
• Sialidases (NanB, NanH): These enzymes cleave sialic acid from host glycoproteins, providing a carbon source and facilitating immune modulation [30, 31].
• Iron Acquisition Systems: The TonB-dependent receptors (ExbB, HgbB, Fur) and the siderophore system (e.g., fur) allow the bacterium to sequester iron from host transferrin and hemoglobin [32, 33].
• Superoxide Dismutases (SodA, SodC): These enzymes neutralize reactive oxygen species produced by host macrophages, enabling intracellular survival [34, 35].

Phase Variation and Lipopolysaccharide Diversity

A critical feature of P. multocida pathogenesis is phase variation in the glycosyltransferase genes responsible for LPS outer core biosynthesis [19]. This phenomenon, involving frameshift mutations in the htpE (heptosyltransferase) and gatG (galactosyltransferase) genes, allows the bacterium to switch between different LPS glycoforms, thereby evading vaccine-induced immunity and facilitating persistent infection [19, 20]. The presence of tandem repeat insertions in natC and single base deletions in homopolymer regions of gatG are the molecular mechanisms underlying this phase variation [19].

Epidemiology

Host Range and Susceptibility

Fowl cholera affects a broad range of avian species, with turkeys and waterfowl (ducks and geese) being particularly susceptible to acute, high-mortality outbreaks [22, 23]. Chickens, especially layers and broilers, are also highly susceptible, although the disease may present in a more chronic or subacute form in some flocks [6, 7]. Wild birds, including waterfowl, raptors, and passerines, serve as natural reservoirs and can introduce the pathogen into domestic poultry operations [12, 22].

Transmission Dynamics

Transmission occurs primarily via the respiratory route through direct contact with infected birds or contaminated fomites (e.g., feed, water, equipment) [9, 10]. The bacterium colonizes the upper respiratory tract (nasal cavity, trachea) and can be shed in oral and nasal secretions, as well as in feces [11, 12]. Aerosol transmission over short distances (within a barn) is facilitated by high stocking densities and poor ventilation [13, 14]. The basic reproduction number (R0) for fowl cholera, as estimated by compartmental SEIATCR models, is highly sensitive to the transmission rate and vaccine efficacy, with treatment and culling being the most effective control interventions [9].

Risk Factors and Predisposing Conditions

Several factors increase the risk of fowl cholera outbreaks:

• Environmental Stressors: Cold, wet weather, poor ventilation, and high ammonia levels compromise the respiratory epithelium and increase susceptibility [22, 23].
• Immunosuppression: Co-infection with immunosuppressive viruses (e.g., infectious bursal disease virus, Marek's disease virus) or mycotoxins (e.g., aflatoxin) reduces vaccine efficacy and increases disease severity [20, 21].
• Nutritional Deficiencies: Iron-restricted diets or suboptimal protein levels impair the host's ability to mount an effective immune response [31, 32].
• Management Practices: High stocking density, poor biosecurity, and introduction of new birds without quarantine are major risk factors [2, 3].

Geographic Distribution and Outbreak Patterns

Fowl cholera is endemic in most poultry-producing regions worldwide, including Asia, Africa, Europe, North America, and Australia [1, 4]. Outbreaks are often seasonal, with peak incidence in the cooler, wetter months (e.g., autumn and spring) [22, 23]. In free-range layer systems, the re-emergence of fowl cholera has been linked to the increased adoption of outdoor access, which exposes birds to wild bird reservoirs and environmental contamination [19, 20].

Clinical Signs and Pathology

Acute Form

The acute form of fowl cholera is characterized by sudden onset, high morbidity (up to 50%), and high mortality (up to 20-40%) within 24-48 hours [6, 7]. Affected birds exhibit:

• Systemic Signs: Fever, depression, anorexia, and ruffled feathers [32, 33].
• Respiratory Signs: Dyspnea, tachypnea, and mucoid discharge from the nares and mouth [34, 35].
• Gastrointestinal Signs: Profuse, watery diarrhea (often greenish or yellowish) and dehydration [22, 23].
• Neurological Signs: In some cases, torticollis (twisted neck) and ataxia are observed due to septicemic meningitis [30, 31].

Chronic Form

The chronic form, which may follow an acute episode or occur as a low-grade infection, is characterized by localized infections:

• Wattle and Sinusitis: Swollen, edematous, and purulent wattles and infraorbital sinuses (often termed "wattle disease") [32, 33].
• Arthritis and Synovitis: Swollen, painful leg and wing joints, with lameness and reluctance to move [34, 35].
• Ocular Signs: Conjunctivitis, corneal opacity, and panophthalmitis [30, 31].
• Respiratory Signs: Rales, tracheal rattle, and chronic respiratory distress [32, 33].

Gross Pathology

At necropsy, the acute form presents with:

• Septicemic Lesions: Petechial and ecchymotic hemorrhages on the serosal surfaces (pericardium, pleura, peritoneum) and in the subcutaneous tissues [6, 7].
• Liver: Multifocal, pinpoint (1-2 mm) white to yellow necrotic foci (focal necrosis) scattered throughout the parenchyma [6, 7].
• Spleen: Splenomegaly with mottled, congested appearance [22, 23].
• Lungs: Pulmonary edema, congestion, and fibrinous pneumonia [34, 35].
• Heart: Pericarditis with fibrinous exudate (vegetative valvular lesions) and myocardial infarction [30, 31].
• Gastrointestinal Tract: Enteritis, with desquamation of intestinal villi and hemorrhagic content [6, 7].

Histopathology

Microscopic examination reveals:

• Vasculitis: Fibrinoid necrosis of blood vessel walls, with perivascular edema and hemorrhage [6, 7].
• Liver: Multifocal coagulative necrosis with infiltration of heterophils and macrophages [6, 7].
• Trachea: Submucosal edema, desquamation of epithelial cells, and infiltration of inflammatory cells [6, 7].
• Joints: Fibrinosuppurative synovitis and arthritis [34, 35].

Diagnosis

Clinical and Epidemiological Diagnosis

A presumptive diagnosis of fowl cholera is based on the characteristic clinical signs (acute septicemia, high mortality, wattle edema) and gross pathology (liver necrosis, pericarditis) [2, 3]. However, definitive diagnosis requires laboratory confirmation.

Bacteriological Isolation and Identification

P. multocida can be isolated from blood, liver, spleen, bone marrow, or tracheal swabs using:

• Culture Media: Blood agar (sheep or horse) or tryptic soy agar (TSA) supplemented with 5% sheep blood, incubated at 37°C for 18-24 hours [4, 5]. The colonies are small, gray, mucoid, and non-hemolytic.
• Biochemical Tests: The organism is catalase positive, oxidase positive, and ferments glucose, sucrose, and mannitol without gas production [14, 15].
• Identification Systems: Commercial biochemical test strips (e.g., API 20NE) or automated systems can provide species-level identification [4, 5].

Molecular Diagnostics

Polymerase chain reaction (PCR) is the gold standard for molecular detection and genotyping:

• Capsular PCR: Multiplex PCR targeting the capA, capB, capD, capE, and capF genes is used for capsular serotyping [4, 5].
• LPS PCR: PCR targeting the hyaD/hyaC and lps loci is used for LPS genotyping [26, 27].
• Multilocus Sequence Typing (MLST): MLST based on seven housekeeping genes (adk, aroE, fumC, gdh, mdh, pgi, recA) provides high-resolution genotyping and is used for epidemiological investigations [26, 27].
• Random Amplification of Polymorphic DNA (RAPD): RAPD analysis is a rapid, low-cost method for strain differentiation and outbreak tracking [21, 22].

Serological Assays

Enzyme-linked immunosorbent assays (ELISAs) are used to measure antibody titers:

• Indirect ELISA: For detection of serum IgG against P. multocida whole-cell or purified antigens [10, 11].
• Sandwich ELISA: For detection of secretory IgA in tracheal and crop lavage samples [10, 11].

Advanced Data Mining and Predictive Modeling

Recent advances in computational biology have enabled the development of predictive models for fowl cholera infection status using machine learning algorithms [2, 3]. Logistic regression, random forest, and gradient boosting models, trained on datasets of bird age, vaccination history, environmental conditions, and clinical symptoms, have achieved high accuracy (up to 94.6%) in predicting disease status [2, 3]. These models are valuable for early warning and targeted surveillance.

Differential Diagnosis

Fowl cholera must be differentiated from other acute septicemic diseases of poultry:

• Avian Influenza (HPAI): Similar clinical signs but with more pronounced neurological signs and higher mortality [1, 2].
• Newcastle Disease (ND): Respiratory and neurological signs, with tracheal hemorrhages and proventricular lesions [16, 17].
• Salmonellosis (Fowl Typhoid): Hepatosplenomegaly, but with characteristic intestinal lesions and isolation of Salmonella spp. [22, 23].
• Colibacillosis: Pericarditis, perihepatitis, and airsacculitis, but with Escherichia coli isolation [16, 17].
• Infectious Coryza: Swollen wattles and sinuses, but with Avibacterium paragallinarum isolation [22, 23].

Treatment

Antimicrobial Therapy

Antimicrobial therapy is the primary treatment for acute fowl cholera outbreaks. The choice of antibiotic should be guided by antibiogram profiling, as resistance is increasingly reported [4, 5]. Commonly used antibiotics include:

• Penicillins: Penicillin G, ampicillin, and amoxicillin are effective against susceptible strains [5, 6].
• Fluoroquinolones: Enrofloxacin, norfloxacin, and ciprofloxacin are effective but resistance (e.g., to levofloxacin) has been documented [4, 5].
• Tetracyclines: Oxytetracycline and doxycycline are broad-spectrum but resistance is common [21, 22].
• Sulfonamides: Trimethoprim-sulfamethoxazole is effective but intermediate sensitivity is reported [5, 6].
• Florfenicol: A broad-spectrum antibiotic with good activity against P. multocida [5, 6].

Probiotic and Bacteriophage Therapy

Novel multi-strain probiotics (e.g., Lactobacillus plantarum, L. fermentum, Pediococcus acidilactici, Enterococcus faecium, Saccharomyces cerevisiae) have been shown to reduce P. multocida colonization, improve growth performance, and attenuate inflammatory responses in broilers [18, 19]. Bacteriophage lysates have also been investigated as a therapeutic alternative to antibiotics, with promising results in reducing mortality [8, 9].

Control and Prevention

Biosecurity

Strict biosecurity measures are essential to prevent the introduction and spread of P. multocida:

• Quarantine: New birds should be isolated for at least 30 days before introduction [22, 23].
• Disinfection: Thorough cleaning and disinfection of housing, equipment, and footwear using quaternary ammonium compounds or hypochlorite [22, 23].
• Rodent and Wild Bird Control: Exclusion of wild birds and rodents from poultry houses and feed storage areas [22, 23].
• Vaccination: Autogenous or commercial inactivated vaccines are the mainstay of prevention [1, 2].

Vaccination

Vaccination is the most effective control measure for fowl cholera. Several vaccine types are available:

• Inactivated Whole-Cell Vaccines: Formalin-inactivated or gamma-irradiated P. multocida whole-cell vaccines, administered intramuscularly or intranasally, induce both humoral (IgG, IgA) and cellular (Th1) immune responses [10, 11, 24, 25].
• Subunit Vaccines: Purified supernatant proteins (e.g., AspA, DgK, RpsF) from iron-restricted cultures have shown protective efficacy (80% protection) in chickens [31, 32].
• Bivalent Vaccines: Combined fowl cholera and avian influenza vaccines have been developed to provide dual protection [1, 2].
• Biofilm Vaccines: Biofilm-based vaccines, using P. multocida grown in biofilm-inducing conditions, have shown enhanced immunogenicity compared to planktonic cultures [13, 14].

Immunopotentiation and Adjuvants

The use of adjuvants is critical for enhancing vaccine immunogenicity:

• Montanide Gel 01 PR: A water-in-oil adjuvant that induces strong IgG and IgA responses [10, 11].
• Carbigen: A carbomer-based adjuvant that promotes mucosal immunity [10, 11].
• Emulsigen-D: A dual-emulsion adjuvant that induces a Th1-dominant response with high IFN-gamma and IL-6 expression [10, 11].
• Aluminum Hydroxide Gel: A traditional adjuvant that enhances humoral immunity [10, 11].

Gamma-Irradiated Vaccines

Gamma irradiation (at 1 kGy) is an effective method for inactivating P. multocida while preserving the structural integrity of surface antigens [10, 11]. Gamma-irradiated vaccines, when administered intranasally or intraocularly, have been shown to provide 100% protection against homologous lethal challenge, with significantly higher secretory IgA and IFN-gamma responses compared to formalin-inactivated vaccines [10, 11, 24, 25].

Culling and Depopulation

In the event of a severe outbreak, rapid culling of infected and exposed birds, followed by disposal (e.g., incineration, composting), is necessary to contain the spread [9, 10]. The SEIATCR model demonstrates that culling, when combined with treatment, is more effective than culling alone in reducing the basic reproduction number [9].

Conclusion

Fowl cholera, caused by Pasteurella multocida, remains a major threat to global poultry production. The bacterium's ability to undergo phase variation in LPS biosynthesis, combined with its diverse virulence factors, makes it a challenging pathogen to control. Effective management requires a multi-pronged approach: robust biosecurity, timely and accurate diagnosis (using both traditional and molecular methods), targeted antimicrobial therapy guided by antibiograms, and vaccination with immunopotentiated vaccines. The integration of advanced data mining and predictive modeling into surveillance systems offers a promising avenue for early detection and intervention. Continued research into the molecular mechanisms of host-pathogen interaction, phase variation, and vaccine development is essential for the sustainable control of this economically important disease.

References

[1] Rafique M, Shahzad A, Jahangir G, et al. Immunopotential of the Combine Vaccine against Fowl Cholera and Avian Influenza Virus in Poultry. Molecular Genetics Microbiology and Virology. 2025.

[2] Amosa BMG, Onyeka NC, Fabiyi AO, et al. Development of a Predictive Model for Fowl-Cholera Infection Status in Poultry Using Advanced Data Mining Analysis Techniques and Logistic Regression Modeling. International Journal of Latest Technology in Engineering Management & Applied Science. 2026.

[3] Ahsan M, Jalees MM, Ashraf W, et al. IMMUNIZATION POTENCY AND PROTECTIVE EFFICACY OF A BIVALENT INACTIVATED FOWL CHOLERA AND AVIAN INFLUENZA VACCINE IN POULTRY. Journal of Population Therapeutics and Clinical Pharmacology. 2024.

[4] Arvia MM, Kurnia R, Nugroho C, et al. Characterization of Pasteurella multocida Isolated from Layer Chickens Infected with Fowl Cholera in Sukabumi, Indonesia: Antibiotic Resistance and Virulence Gene Detection. World's Veterinary Journal. 2025.

[5] Geda AM, Wendimu A, Lulie S, et al. Molecular Detection and Antibiogram Profiling of Pasteurella multocida Isolated From Breeder Chickens Suspected of Fowl Cholera in Gondar City, Ethiopia. International Journal of Microbiology. 2025.

[6] Aliza D, Hasan D, Nazaruddin N, et al. Diagnosis of Fowl Cholera in Broiler Chicken Collected from Banda Aceh and Aceh Besar. Jurnal Medika Veterinaria. 2024.

[7] Geda AM. Fowl Cholera in Chickens: Current Trends in Diagnosis and Phenotypic Drug Resistance in Gondar City, Ethiopia. Veterinary Medicine International. 2024.

[8] Ramchandran D, Verma H, Prajapati A, et al. Application of bacteriophage lysate for treatment of fowl cholera in poultry. 2012.

[9] Malek A. Dynamics of cholera transmission in poultry farm: insights from a compartmental model and control strategies. British Poultry Science. 2025.

[10] Belay E, Bitew M, Ibrahim SM, et al. Gamma-irradiated fowl cholera vaccines formulated with different adjuvants induced antibody response and cytokine expression in chickens. Frontiers in Immunology. 2025.

[11] Tsai HJ, You WB. Short communication. Occurrence of fowl cholera in poultry flocks in Taiwan. 2000.

[12] Petersen KD, Christensen J, Permin A, et al. Virulence of Pasteurella multocida subsp. multocida isolated from outbreaks of fowl cholera in wild birds for domestic poultry and game birds. Avian Pathology. 2001.

[13] Ramesh PT. Comparative Evaluation of Biofilm Vaccine with other Conventional Vaccines Against Fowl Cholera in Poultry Layer Birds. 2006.

[14] Kardos G, Kiss I. Molecular Epidemiology Investigation of Outbreaks of Fowl Cholera in Geographically Related Poultry Flocks. Journal of Clinical Microbiology. 2005.

[15] Abhilash M, Kannaki T, Priyanka E, et al. Immunogenicity and Protective Efficacy of Iron-inactivated Pasteurella multocida A:1 Vaccine against Fowl Cholera in Backyard Chicken. Indian Journal of Animal Research. 2021.

[16] Ookanti S. Co-infection of Fowl Cholera with bacterial and viral infection in poultry flocks.

[17] ISOLATION AND MOLECULAR IDENTIFICATION OF PASTEURELLA MULTOCIDA FROM COMMERCIAL POULTRY FARMS SUFFERING FROM FOWL CHOLERA. International Journal of Biology Pharmacy and Allied Sciences. 2019.

[18] Reuben R, Sarkar S, Ibnat H, et al. Novel multi-strain probiotics reduces Pasteurella multocida induced fowl cholera mortality in broilers. Scientific Reports. 2021.

[19] Omaleki L, Blackall P, Cuddihy TP, et al. Phase variation in the glycosyltransferase genes of Pasteurella multocida associated with outbreaks of fowl cholera on free-range layer farms. Microbial Genomics. 2022.

[20] Hegazy S, Azzam A, Gabal MA. Interaction of naturally occurring aflatoxins in poultry feed and immunization against fowl cholera. Poultry Science. 1991.

[21] Saha O, Islam MR, Rahman MS, et al. First report from Bangladesh on genetic diversity of multidrug-resistant Pasteurella multocida type B:2 in fowl cholera. Veterinary World. 2021.

[22] Hassan N, Hamadani H, Zargar UR. Rare Outbreak of Fowl Cholera in Waterfowls in Dal Lake Area of Kashmir, with Isolation, Antibiogram and Successful Treatment - A Report. 2017.

[23] Wickramasinghe R, Peiris H. An outbreak of fowl cholera in a poultry farm in Sri Lanka. 1985.

[24] Dessalegn B, Bitew M, Asfaw D, et al. Gamma-Irradiated Fowl Cholera Mucosal Vaccine: Potential Vaccine Candidate for Safe and Effective Immunization of Chicken Against Fowl Cholera. Frontiers in Immunology. 2021.

[25] Kardos G, Kiss I. Molecular Epidemiology Investigation of Outbreaks of Fowl Cholera in Geographically Related Poultry Flocks. 2005.

[26] Lai VD, Kim JS, Mo I. Multilocus Sequence Typing of Pasteurella multocida Isolates from Acute Fowl Cholera Outbreak in Layer. Korean Journal of Poultry Science. 2020.

[27] Saha O, Islam MR, Rahman MS, et al. Genome-wide diversity and differentiation of two novel multidrug-resistant populations of Pasteurella multocida type B:2 from fowl cholera. bioRxiv. 2020.

[28] Wubet W, Bitew M, Mamo G, et al. Evaluation of inactivated vaccine against fowl cholera developed from local isolates of Pasteurella multocida in Ethiopia. 2019.

[29] Fasina Y, Suarez DL, Ritter GD, et al. Unraveling frontiers in poultry health (part 1) – Mitigating economically important viral and bacterial diseases in commercial Chicken and Turkey production. Poultry Science. 2024.

[30] Blakey J, Crispo M, Bickford A, et al. Fowl cholera and acute heart rupture in a backyard turkey. Journal of Veterinary Diagnostic Investigation. 2019.

[31] Luo Q, Kong L, Dong J, et al. Protection of chickens against fowl cholera by supernatant proteins of Pasteurella multocida cultured in an iron-restricted medium. Avian Pathology. 2019.

[32] Salama S, Fatma M, Gadallah F, et al. Uses of single dose dependent and relative potency assays for the evaluation of inactivated fowl cholera vaccine. Journal of Bacteriology & Mycology: Open Access. 2019.

[33] Salama S, Gadallah F, Abo-elkhir F, et al. Uses of Single Dose Dependent and Relative Potency Assays for Evaluation of Inactivated Fowl Cholera Vaccine. The Journal of World's Poultry Research. 2019.

[34] Poolperm P, Apinda N, Kataoka Y, et al